DRUGS FOR SYMPTOMATIC TREATMENT OF HUNTINGTON'S DISEASE: A NEURODEGENERATIVE DISORDER

Journal Title: Journal of Biomedical and Pharmaceutical Research - Year 2013, Vol 2, Issue 6

Abstract

Huntington’s disease is a devastating inherited neurodegenerative disease characterized by progressive motor, cognitive, and psychiatric symptoms. Patients may present with any of these symptoms, and familiarity with the phenotype is therefore important. Chorea and loss of balance are early symptoms that patients notice, although families often notice cognitive or personality changes before this. Although no therapy is currently available to delay the onset of symptoms or prevent the progression of the disease, symptomatic treatment of patients with Huntington disease (HD) may improve the quality of life and prevent complications. As is the case with other neurological diseases, HD makes individuals more vulnerable to side effects from medications, particularly cognitive adverse effects. Symptomatic treatment for HD can be divided into drugs to treat the movement disorder and drugs to treat psychiatric or behavioral problems. Symptomatic treatment of Huntington’s disease involves use of Dopamine antagonists, presynaptic dopamine depleters, Antidepressants, Tranquillizers, Anxiolytic Benzodiazepines, Anticonvulsants and Antibiotics. Several medications including baclofen, idebenone and vitamin E have studied in clinical trials with limited samples. This article reviews current therapeutic agents for treatment of the symptoms of Huntington’s disease. The aim of present article is to provide in depth knowledge about symptomatic treatment and other therapies involved in the management of Huntington’s disease.

Authors and Affiliations

Pranab Prakash Panigrahi*| Executive, QC (Stability), Aurobindo Pharma Ltd., Mahaboob Nagar, Andhra Pradesh, India-509302

Keywords

Related Articles

OPTIMUM DESIGN AND ANALYSIS OF RECTANGULAR MICROCANTILEVER FOR HUMAN IMMUNODEFICIENCY VIRUS DETECTION

Microcantilever based sensors is a promising platform for sensors in various chemical and biological applications. Rectangular microcantilever is commonly used biosensing device for the detection of various disease detec...

EFFECT OF POSTMENOPAUSAL STATUS ON SERUM LIPIDS PROFILE AND URIC ACID IN SUDANESE FEMALES FROM THE GENERAL POPULATION

BACKGROUND: Previous data suggest possible effects of postmenopause on serum lipids profile and uric acid which are established risk factors for cardiovascular system. AIM: to evaluate the changes that may occur on ser...

ANTIDIABETIC ACTIVITY OF 2-AMINO-(5-FLUORO-2-OXOINDOLIN-3-YLIDENE) BENZOXAZOLE-5-CARBOHYDRAZIDE IN RATS

The present study was designed to evaluate the antidiabetic activity of new indole derivatives i.e 2-Amino-(5-fluoro-2-oxoindolin-3-ylidene) benzoxazole-5-carbohydrazide against alloxan induced diabetic rats. Alloxan (12...

An Injection without the Needle: Iontophoresis

Penetration of healthy skin by drugs in solution is normally very limited due to the excellent barrier function of the stratum corneum (the most superficial layer of the skin). This barrier can be overcome using iontopho...

To Study the Mechanisms of Granule Formation in the Wet Granulation Process

Traditionally wet agglomeration processes have been considered an empirical art, with great difficulties in predicting and explaining observed behavior. Industry has faced a range of problems including poor product quali...

Download PDF file
  • EP ID EP2352
  • DOI -
  • Views 338
  • Downloads 22

How To Cite

Pranab Prakash Panigrahi* (2013). DRUGS FOR SYMPTOMATIC TREATMENT OF HUNTINGTON'S DISEASE: A NEURODEGENERATIVE DISORDER. Journal of Biomedical and Pharmaceutical Research, 2(6), 13-18. https://europub.co.uk/articles/-A-2352